Harbin Pharmaceutical Group

Harbin Pharmaceutical Group (also known as Hayao) is a Chinese pharmaceutical company, and one of the largest in the country. It is headquartered in Harbin, in the Heilongjiang province of China. The company is involved in the research, development, manufacture, and sale of a wide range of pharmaceutical products.

History

Harbin Pharmaceutical Group was established in 1958. Over the years, it has grown into a large-scale pharmaceutical enterprise with six listed companies and more than 20,000 employees. The company has a strong presence in the Chinese pharmaceutical market and also exports its products to more than 40 countries and regions.

Products and Services

Harbin Pharmaceutical Group's product portfolio includes both prescription and over-the-counter (OTC) drugs. The company produces a wide range of pharmaceutical products, including antibiotics, cardiovascular drugs, neurological drugs, anti-cancer drugs, and traditional Chinese medicine.

In addition to pharmaceutical products, Harbin Pharmaceutical Group also provides pharmaceutical research and development services. The company has a state-of-the-art R&D center and collaborates with many domestic and international research institutions.

Financial Performance

Harbin Pharmaceutical Group has shown steady financial performance over the years. The company's revenue and profits have been growing steadily, reflecting the strong demand for its products and services.

Future Outlook

With its strong product portfolio and R&D capabilities, Harbin Pharmaceutical Group is well-positioned to capitalize on the growing demand for pharmaceutical products in China and globally. The company is expected to continue its growth trajectory in the coming years.

See Also

• Pharmaceutical industry in China
• List of pharmaceutical companies